These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8110496)
21. The potential for a novel pure anti-oestrogen. Wakeling AE Horm Res; 1989; 32 Suppl 1():257-9; discussion 260. PubMed ID: 2613211 [TBL] [Abstract][Full Text] [Related]
22. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281 [TBL] [Abstract][Full Text] [Related]
23. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line. Parisot JP; Hu XF; DeLuise M; Zalcberg JR Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856 [TBL] [Abstract][Full Text] [Related]
24. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Toi M; Harris AL; Bicknell R Br J Cancer; 1993 Dec; 68(6):1088-96. PubMed ID: 8260359 [TBL] [Abstract][Full Text] [Related]
25. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017 [TBL] [Abstract][Full Text] [Related]
26. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. Westley BR; Hölzel F; May FE J Steroid Biochem; 1989 Mar; 32(3):365-72. PubMed ID: 2468045 [TBL] [Abstract][Full Text] [Related]
27. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells. Chalbos D; Philips A; Galtier F; Rochefort H Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199 [TBL] [Abstract][Full Text] [Related]
28. A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer. Fan P; Agboke FA; Cunliffe HE; Ramos P; Jordan VC Eur J Cancer; 2014 Nov; 50(16):2866-76. PubMed ID: 25204804 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578 [TBL] [Abstract][Full Text] [Related]
30. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
31. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435 [TBL] [Abstract][Full Text] [Related]
32. Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells. Wiseman LR; Wakeling AE; May FE; Westley BR J Steroid Biochem; 1989 Jul; 33(1):1-6. PubMed ID: 2761257 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
34. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Nicholson RI; Gee JM; Manning DL; Wakeling AE; Montano MM; Katzenellenbogen BS Ann N Y Acad Sci; 1995 Jun; 761():148-63. PubMed ID: 7625718 [No Abstract] [Full Text] [Related]
35. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. Molloy CA; May FE; Westley BR J Biol Chem; 2000 Apr; 275(17):12565-71. PubMed ID: 10777546 [TBL] [Abstract][Full Text] [Related]
36. The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Levenson AS; Tonetti DA; Jordan VC Br J Cancer; 1998 Jun; 77(11):1812-9. PubMed ID: 9667651 [TBL] [Abstract][Full Text] [Related]
37. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Borley AC; Hiscox S; Gee J; Smith C; Shaw V; Barrett-Lee P; Nicholson RI Breast Cancer Res; 2008; 10(6):R103. PubMed ID: 19055788 [TBL] [Abstract][Full Text] [Related]
38. [The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen]. Borgna JL Bull Cancer; 1994 Jan; 81(1):29-37. PubMed ID: 7949581 [TBL] [Abstract][Full Text] [Related]
39. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866 [TBL] [Abstract][Full Text] [Related]
40. The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain. Damien E; Price JS; Lanyon LE J Bone Miner Res; 1998 Aug; 13(8):1275-82. PubMed ID: 9718196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]